-
Mashup Score: 0
Obesity increases the risk of heart failure with preserved ejection fraction. Tirzepatide, a long-acting agonist of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor…
Source: www.nejm.orgCategories: General Medicine News, Expert PicksTweet
-
Mashup Score: 0Nasal Bumetanide Safe, Effective in Healthy Adults - 12 day(s) ago
(UPDATED) A nasal spray would be a workaround for drug resistance seen with oral diuretics, with the potential to reduce hospital visits.
Source: www.tctmd.comCategories: General Medicine News, CardiologistsTweet-
Preliminary randomized data finds that bumetanide taken as a nasal spray is safe and effective in healthy adults. @EricAdler17 explains, βThe idea here was to develop a parenteral alternative to [oral and] intravenous diuretics.β #AHA24 https://t.co/DjXPHXDAKH https://t.co/ZAADLZWT7Y
-
-
Mashup Score: 13Cardiac Failure With Robert J. Mentz, MD, and Anuradha Lala, MD - 12 day(s) ago
Drs. Robert J. Mentz, MD, and Anuradha Lala, MD, are world-renowned cardiologists and Co-Editors in Chief of JCF. Dr. Robert Mentz is an Associate Professor of Medicine and Chief of the Heart Failure Section at Duke University while Dr. Lala is an Associate Professor of Medicine at the Zena & Michael A Wiener Cardiovascular Institute and in the Department of Population Health Science and Statistics at Icahn School of Mount Sinai and Mount Sinai Hospital.
Source: mashupmd.comCategories: General Medicine News, General HCPsTweet-
Check out some interesting studies that you may have missed from #AHA24! πRead more from @robmentz & @dranulala: https://t.co/bnzCTAPjKx https://t.co/EOs2ZYHgmf
-
-
Mashup Score: 7
Join us for a live symposium on antithrombotic therapy where leaders in the field will exchange ideas on the latest advances in thromboembolic disease manage…
Source: www.youtube.comCategories: General Medicine News, CardiologistsTweet-
π©Έ Do not miss this ππππ #πππππ π«ππππ© as renowned faculty review key insights re: thromboembolic disease prevention and management. β‘οΈ https://t.co/2EAnxXaUPI π€ Join @dlbhattmd, @gbarnesmd, @DKadiandodov on Dec 13! https://t.co/ZhTtRRAivP
-
-
Mashup Score: 0
Transthyretin amyloidosis with cardiomyopathy (ATTR-CM) is a progressive, often fatal disease. Nexiguran ziclumeran (nex-z) is an investigational therapy based on CRISPR-Cas9 (clustered regularly i…
Source: www.nejm.orgCategories: General Medicine News, Cardiologists1Tweet-
#AHA24 - "nex-z" CRISPR-based one-time infusion targeting TTR. Dramatically reduce serum TTR in pts with ATTR-CM. stability or improvement in symptoms for most pts. https://t.co/bmdMPLosT0
-
-
Mashup Score: 25Does STEMI Need a Rebrand to βOcclusion MIβ? - 15 day(s) ago
A review paper prompted a discussion among cardiologists Bob Harrington, Manesh Patel, and Michael Gibson on whether the ST-segment elevation myocardial infarction paradigm needs an update.
Source: www.medscape.comCategories: General Medicine News, CardiologistsTweet-
Fun discussion w @CMichaelGibson and @manesh_patelMD #aha24 discussing proposed new paradigm for MI care. From Q waves at discharge to STE to ECG/angio informing AI models. Thanks @_triciaward @theheartorg https://t.co/ln3O5MzVrX
-
-
Mashup Score: 7
Join us for a live symposium on antithrombotic therapy where leaders in the field will exchange ideas on the latest advances in thromboembolic disease manage…
Source: www.youtube.comCategories: General Medicine News, CardiologistsTweet-
π©Έ Do not miss this ππππ #πππππ π«ππππ© as renowned faculty review key insights re: thromboembolic disease prevention and management. β‘οΈ https://t.co/2EAnxXaUPI π€ Join @dlbhattmd, @gbarnesmd, @DKadiandodov on Dec 13! https://t.co/ZhTtRRAivP
-
-
Mashup Score: 5
Join us for a live symposium on antithrombotic therapy where leaders in the field will exchange ideas on the latest advances in thromboembolic disease manage…
Source: www.youtube.comCategories: General Medicine News, CardiologistsTweet-
π©Έ Do not miss this ππππ #πππππ π«ππππ© as renowned faculty review key insights re: thromboembolic disease prevention and management. β‘οΈ https://t.co/2EAnxXaUPI π€ Join @dlbhattmd, @gbarnesmd, @DKadiandodov on Dec 13! https://t.co/ZhTtRRAivP
-
-
Mashup Score: 360
Effective targets for systolic blood-pressure control in patients with type 2 diabetes are unclear. We enrolled patients 50 years of age or older with type 2 diabetes, elevated systolic blood press…
Source: www.nejm.orgCategories: General Medicine News, Expert PicksTweet-
New @NEJM and #AHA24 A large randomized trial in people with Type 2 diabetes showed intensive BP lowering (systolic < 120 mm Hg) reduced major cardiovascular outcomes https://t.co/qyjspdaK3d https://t.co/AxfBJOdbOY
-
-
Mashup Score: 2
CHICAGO β Survivors of an acute MI reported fear of a recurrence up to 8 months later, along with high levels of perceived stress that were distinct from depression and anxiety symptoms, researchers reported.βFear of recurrence is a significant mental health issue in post-heart attack survivors,β Sarah E. Zvonar, PhD, RN, CCRN, a postdoctoral researcher at Indiana University,
Source: www.healio.comCategories: General Medicine News, CardiologistsTweet-
Survivors of an acute MI reported fear of a recurrence up to 8 months later, along with high levels of perceived stress that were distinct from depression and anxiety symptoms @sezvonar @iunursing @unlv #AHA24 @American_Heart @HeartNews https://t.co/h6jvFkFykR
-
π @NEJM #AHA24 https://t.co/4vbqJOaHyz https://t.co/5Y7zboenYB